A recent study suggested that shopping data may help predict the risk of cancer. Now, researchers are exploring the implications of that finding.
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
The MonumenTAL-1, MajesTEC-2, OPTIMUM/MUKnine, and GMMG-CONCEPT trials have shown promising results for patients with newly diagnosed or relapsed/refractory multiple myeloma.
Data suggest that most patients who use medical aid in dying (MAID) have cancer, but some oncology providers do not feel well informed about MAID.
Changes to abortion laws in the US could have unintended consequences for cancer patients and others seeking fertility preservation.
Experts outline ways in which health care providers and employers can support cancer patients and caregivers in the workplace.
Of more than 2500 trials analyzed, 21% were randomized.
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
The biosimilars proved as effective as the original biologics in all cancers studied.
Sugemalimab demonstrated efficacy in combination with chemotherapy and as consolidation after chemoradiotherapy.
